Dark Forest Capital Management LP Vir Biotechnology, Inc. Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $480,704 - $565,448	20,720 Added 226.27%	29,877 $732,000
Q1 2023 May 12, 2023	BUY	$22.26 - $30.85 $203,834 - $282,493	9,157 New	9,157 $213,000
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $1,316 - $1,842	69 New	69 $2,000
Q1 2022 May 13, 2022	SELL	$21.19 - $40.01 $1,017 - $1,920	-48 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$30.97 - $54.03 $28,678 - $50,031	-926 Reduced 95.07%	48 $2,000
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $9,248 - $14,453	265 Added 37.38%	974 $42,000
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $27,473 - $36,159	709 New	709 $34,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.